Today, we announced our third-quarter 2022 financial results and provided a business update and outlook for the remainder of the year.

Discover more here: argenx.com/investors/even…

#TogetherWeDiscover

Join us for a conference call and audio webcast on 10/27 for our Q3 2022 financial results and business update.

Register here: argenx.com/investors/even…

#TogetherWeDiscover

This month we join Dysautonomia Intl. to raise awareness for #DysautonomiaAwarenessMonth . Discover their feed to learn more about this #RareDisease 👇

#TogetherWeDiscover

Join us in celebrating Marieke Lowers, Director of Strategic Alliances, for winning the TOPX Network Females to Follow award! Marieke has been an exemplary leader, we are proud to call her an #Argonaut ! 👏👏

#WomenInLeadership #biotech #TogetherWeDiscover

We had the pleasure of participating in the Fierce New Product Planning
Summit 2022. Arjen Lemmen, VP of Corporate Development and Strategy, spoke about implementing a values-focused thought process to improve early portfolio decisions. Thank you for having us Fierce Life Sciences Events!

#WorldMentalHealthDay reminds us of how important it is to prioritize the activities that help us manage our mental and physical health. #Biotech leaders, how are you supporting your team’s #MentalHealth ?

#TogetherWeDiscover

🏆 We are a PM360online Trailblazer Award winner! Innovating for patients around the world is our core mission - join us in celebrating receiving four awards that directly reflect our commitment to this mission.

#TogetherWeDiscover #PM360TrailblazerAwards

Thank you for your partnership MGA at #AANEMinNashville ! Your contribution is essential to better serve the #RareDisease and generalized #MyastheniaGravis communities.

#AANEMinNashville has provided us the opportunity to connect with #neurologists and have insightful conversations on how we can better serve people living with #RareDiseases .

#TogetherWeDiscover #AANEM22 #NeuromuscularDisorders

Calling all #AANEM22 attendees! - Stop by booth #307 for a product demo on the first FcRn blocker for generalized #MyastheniaGravis .

#TogetherWeDiscover #Neurology #AANEMinNashville

Hello, #NeuroTwitter ! I’m Leslie McGeehen, Regional Business Director at argenx. I’m excited to be back at #AANEM22 for another year, take a look at what argenx has in store for this year!

#TogetherWeDiscover #AANEMinNashville

The Argonauts kicked off #AANEM22 with the @myastheniaorg MG Scientific Session. We look forward to discussing the latest trends and findings on generalized #MyastheniaGravis .

If you are attending, come see us at booth #307.

#TogetherWeDiscover #AANEMinNashville

#BreakingNews : Today we submitted a Biologics License Application (BLA) to the FDA for our subcutaneously administered FcRn blocker.

Discover more here: bit.ly/3BXFKIr

#TogetherWeDiscover

For #ITPAwarenessMonth , Anna Hultberg, Senior Scientist, shares information about the biology behind this rare, often chronic bleeding disorder.

Discover more: argenx.com/patients/immun…

#TogetherWeDiscover #ScienceFacts #ITPawareness

From Boston to Ghent to Japan, the #Argonauts enjoyed some well-deserved time off around the world this summer. What’s your favorite vacation spot?

Discover more about life at argenx: argenx.com/careers

#TogetherWeDiscover #BiotechCareers

Join us in welcoming Camilla Sylvest to our Board of Directors. Camilla’s proven dedication to company culture and sustainability will support our vision to be an integrated, #immunology company.

bit.ly/3xd4aeq
#TogetherWeDiscover

#DYK ? September is #ITPAwarenessMonth . Scroll to learn more about this #RareDisease 👇

argenx.com/patients/immun…

#TogetherWeDiscover #ITPStrongerTogether #ITPaware ness #ITPstrong #ITPaware #KnowledgeIsPower

Congratulations to our very own Shikhar Agarwal on winning the PM360 Trailblazer Award Brand Champion in the Autoimmune category.

Thank you for all you do to inspire the argenx team and support people with rare, autoimmune diseases.

prnewswire.com/news-releases/…